Aroa Biosurgery Ltd
ASX:ARX

Watchlist Manager
Aroa Biosurgery Ltd Logo
Aroa Biosurgery Ltd
ASX:ARX
Watchlist
Price: 0.56 AUD 1.82% Market Closed
Market Cap: 193.1m AUD

Intrinsic Value

The intrinsic value of one ARX stock under the Base Case scenario is 1.37 AUD. Compared to the current market price of 0.56 AUD, Aroa Biosurgery Ltd is Undervalued by 59%.

The Intrinsic Value is calculated as the average of DCF and Relative values:

ARX Intrinsic Value
1.37 AUD
Undervaluation 59%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation History
Aroa Biosurgery Ltd

Valuation History Unavailable

Historical valuation for ARX cannot be conducted due to limitations such as insufficient data or other constraints.

Valuation In Progress...
Valuation In Progress...
0%
Compare ARX to

Fundamental Analysis

Company Overview
Loading...
Earnings Call
Loading...
Management
Loading...
Contacts
Loading...
How do you feel about ARX?
Bearish
Neutral
Bullish
AI Assistant
AI Assistant
Ask me anything about Aroa Biosurgery Ltd
Financials
Annual
Quarterly
TTM

Balance Sheet Decomposition
Aroa Biosurgery Ltd

Current Assets 68.2m
Cash & Short-Term Investments 22.1m
Receivables 35.4m
Other Current Assets 10.7m
Non-Current Assets 40.7m
PP&E 21.5m
Intangibles 19.1m
Other Non-Current Assets 82k
Efficiency

Free Cash Flow Analysis
Aroa Biosurgery Ltd

Last Value
3-Years Average
FCF Margin
Conversion Rate

Earnings Waterfall
Aroa Biosurgery Ltd

Revenue
84.7m NZD
Cost of Revenue
-12.1m NZD
Gross Profit
72.6m NZD
Operating Expenses
-75.5m NZD
Operating Income
-2.9m NZD
Other Expenses
-895k NZD
Net Income
-3.8m NZD
Fundamental Scores

ARX Profitability Score
Profitability Due Diligence

Aroa Biosurgery Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Years Revenue Growth
Exceptional Revenue Growth Forecast
ROIC is Increasing
38/100
Profitability
Score

Aroa Biosurgery Ltd's profitability score is 38/100. The higher the profitability score, the more profitable the company is.

ARX Solvency Score
Solvency Due Diligence

Aroa Biosurgery Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Short-Term Solvency
Long-Term Solvency
99/100
Solvency
Score

Aroa Biosurgery Ltd's solvency score is 99/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

ARX Price Targets Summary
Aroa Biosurgery Ltd

Wall Street analysts forecast ARX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ARX is 0.83 AUD with a low forecast of 0.76 AUD and a high forecast of 0.95 AUD.

Lowest
Price Target
0.76 AUD
35% Upside
Average
Price Target
0.83 AUD
49% Upside
Highest
Price Target
0.95 AUD
69% Upside
View Analyst Estimates
View Analyst Estimates

Dividends

Aroa Biosurgery Ltd
does not pay dividends
Shareholder Yield

Current shareholder yield for ARX is .

Shareholder yield represents the total return a company provides to its shareholders, calculated as the sum of dividend yield, buyback yield, and debt paydown yield. What is shareholder yield?

Shareholder Yield
Dividend Yield
No dividends
Buyback Yield
Lowest
Average
Highest
Debt Paydown Yield
Lowest
Average
Highest

Competitive Landscape

Company Market Cap Intrinsic Valuation Profitability Solvency Price Change
1Y 3Y 5Y

Ownership

ARX Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one ARX stock?

The intrinsic value of one ARX stock under the Base Case scenario is 1.37 AUD.

Is ARX stock undervalued or overvalued?

Compared to the current market price of 0.56 AUD, Aroa Biosurgery Ltd is Undervalued by 59%.

Back to Top